A. Plantade

888 total citations
17 papers, 590 citations indexed

About

A. Plantade is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, A. Plantade has authored 17 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in A. Plantade's work include Ovarian cancer diagnosis and treatment (4 papers), Renal cell carcinoma treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). A. Plantade is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Renal cell carcinoma treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). A. Plantade collaborates with scholars based in France, United States and Luxembourg. A. Plantade's co-authors include Bernard Escudier, Ronald M. Bukowski, Alain Ravaud, Brian I. Rini, Toni K. Choueiri, Sylvie Négrier, Paul Elson, Stéphane Oudard, Ming Zhou and Christophe Louvet and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

A. Plantade

16 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Plantade France 8 381 323 220 144 107 17 590
Sonia Yip Australia 14 361 0.9× 84 0.3× 83 0.4× 308 2.1× 90 0.8× 75 662
Geraldine Goss Australia 13 494 1.3× 137 0.4× 111 0.5× 452 3.1× 132 1.2× 24 819
Michael B. Campion United States 17 305 0.8× 100 0.3× 193 0.9× 287 2.0× 35 0.3× 33 715
Xi‐Lei Zhou China 13 336 0.9× 497 1.5× 550 2.5× 286 2.0× 23 0.2× 23 1.1k
Véronique Mari France 10 189 0.5× 78 0.2× 173 0.8× 310 2.2× 30 0.3× 32 496
P. Comella Italy 19 378 1.0× 148 0.5× 142 0.6× 656 4.6× 37 0.3× 65 829
Jian-ying Ma China 12 110 0.3× 164 0.5× 195 0.9× 319 2.2× 21 0.2× 24 513
Giorgio Maria Verdecchia Italy 13 111 0.3× 102 0.3× 88 0.4× 169 1.2× 128 1.2× 22 490
Yiping Du China 9 132 0.3× 259 0.8× 346 1.6× 387 2.7× 16 0.1× 13 703
I. Ray-Coquard France 9 437 1.1× 77 0.2× 89 0.4× 352 2.4× 87 0.8× 28 712

Countries citing papers authored by A. Plantade

Since Specialization
Citations

This map shows the geographic impact of A. Plantade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Plantade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Plantade more than expected).

Fields of papers citing papers by A. Plantade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Plantade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Plantade. The network helps show where A. Plantade may publish in the future.

Co-authorship network of co-authors of A. Plantade

This figure shows the co-authorship network connecting the top 25 collaborators of A. Plantade. A scholar is included among the top collaborators of A. Plantade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Plantade. A. Plantade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ray‐Coquard, Isabelle, Laure Favier, B. Weber, et al.. (2013). Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO. British Journal of Cancer. 108(9). 1771–1777. 73 indexed citations
2.
Lheureux, Stéphanie, Sophie Krieger, B. Weber, et al.. (2012). Expected Benefits of Topotecan Combined With Lapatinib in Recurrent Ovarian Cancer According to Biological Profile. International Journal of Gynecological Cancer. 22(9). 1483–1488. 30 indexed citations
3.
Massard, Christophe, A. Plantade, Marine Gross‐Goupil, et al.. (2010). Poor prognosis nonseminomatous germ-cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?. Annals of Oncology. 21(8). 1585–1588. 29 indexed citations
4.
Choueiri, Toni K., A. Plantade, Paul Elson, et al.. (2007). Efficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell Carcinoma. Journal of Clinical Oncology. 26(1). 127–131. 311 indexed citations
5.
Chauchereau, Anne, Sylvestre Le Moulec, G. Fromont, et al.. (2007). Establishment of a new human prostate cancer cell line, IGR-CaP1, from a localized epithelial prostate cancer.. Cancer Research. 67. 3880–3880. 1 indexed citations
6.
Fizazi, Karim, Christophe Massard, Sophie Postel‐Vinay, et al.. (2007). Chemotherapy for poor prognosis non seminomatous germ cell tumors (NSGCT): Should doses be reduced at first cycle to prevent acute respiratory distress syndrome (ARDS) in patients with multiple lung metastases?. Journal of Clinical Oncology. 25(18_suppl). 5087–5087. 3 indexed citations
7.
Farace, Françoise, Philippe Vielh, A. Plantade, et al.. (2007). Circulating endothelial cells and progenitor cells in metastatic renal cell cancer: Predictive value during anti-angiogenic therapy?. Journal of Clinical Oncology. 25(18_suppl). 3555–3555. 1 indexed citations
8.
Plantade, A., Christophe Massard, R. de Crevoisier, & Karim Fizazi. (2007). [Locally advanced prostate cancer: definition, prognosis and treatment].. PubMed. 94(7 Suppl). F50–61. 4 indexed citations
9.
Laplanche, A., Philippe Beuzeboc, J. Lumbroso, et al.. (2007). A phase II trial of docetaxel and samarium in patients with bone metastases from castration-refractory prostate cancer (CRPC). Journal of Clinical Oncology. 25(18_suppl). 5122–5122. 3 indexed citations
10.
Plantade, A., Toni K. Choueiri, Bernard Escudier, et al.. (2007). Treatment outcome for metastatic papillary and chromophobe renal cell carcinoma (RCC) patients treated with tyrosine-kinase inhibitors (TKIs) sunitinib and sorafenib. Journal of Clinical Oncology. 25(18_suppl). 5037–5037. 14 indexed citations
11.
Lassau, Nathalie, Serge Koscielny, L. Chami, et al.. (2007). 1008 POSTER Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification for the early evaluation of metastatic renal cancer treated with tyrosine kinase inhibitors. European Journal of Cancer Supplements. 5(4). 137–137. 1 indexed citations
12.
Plantade, A., et al.. (2007). 4525 POSTER Self evaluation of side-effects of patients treated sequentially with sunitinib and sorafenib in kidney cancer. European Journal of Cancer Supplements. 5(4). 306–306. 1 indexed citations
13.
Mabro, May, Pascal Artru, Thierry André, et al.. (2006). A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients. British Journal of Cancer. 94(9). 1287–1292. 35 indexed citations
14.
Blanchard, Pierre, A. Plantade, Cécile Pagès, et al.. (2006). Isolated lymph node relapse of epithelial ovarian carcinoma: Outcomes and prognostic factors. Gynecologic Oncology. 104(1). 41–45. 46 indexed citations
15.
Plantade, A., Pauline Afchain, C. Tournigand, et al.. (2006). Chemotherapy-free intervals (CFI) in patients with metastatic colorectal cancer (MRC). Journal of Clinical Oncology. 24(18_suppl). 3581–3581. 4 indexed citations
16.
Tournigand, Christophe, et al.. (2005). Docetaxel (D) and oxaliplatin (DOCELOX) in advanced ovarian cancer (AOC): Preliminary safety results of a phase I-II. Journal of Clinical Oncology. 23(16_suppl). 5104–5104. 5 indexed citations
17.
Plantade, A., et al.. (2003). Diffusely Increased F-18 FDG Uptake in Bone Marrow in a Patient With Acute Anemia and Recent Erythropoietin Therapy. Clinical Nuclear Medicine. 28(9). 771–772. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia Yip Breakdown of academic impact, for papers by Geraldine Goss Breakdown of academic impact, for papers by Michael B. Campion Breakdown of academic impact, for papers by Xi‐Lei Zhou Breakdown of academic impact, for papers by Véronique Mari Breakdown of academic impact, for papers by P. Comella Breakdown of academic impact, for papers by Jian-ying Ma Breakdown of academic impact, for papers by Giorgio Maria Verdecchia Breakdown of academic impact, for papers by Yiping Du Breakdown of academic impact, for papers by I. Ray-Coquard
Rankless by CCL
2026